Mast cells in hemangioma: a double-edged sword
Zhi-Jun Sun1, Yi-Fang Zhao, Ji-Hong Zhao
1Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, 237# Luo Yu Road, Wuhan, Hubei, PR China.
Medical Hypotheses
|October 28, 2006
Summary
Mast cells influence hemangioma development by releasing factors that promote or inhibit blood vessel growth. Understanding these dual roles is key to developing new hemangioma treatments.
Area of Science:
- Vascular Biology
- Immunology
- Dermatology
Background:
- Hemangioma is a common benign vascular tumor with distinct growth phases.
- Mast cells are immune cells involved in inflammation and blood vessel formation (angiogenesis).
Purpose of the Study:
- To investigate the dual role of mast cells in different stages of hemangioma.
- To explore mast cell mediators in regulating hemangioma angiogenesis.
Main Methods:
- Analysis of mast cell numbers and mediator roles in hemangioma phases.
- Review of existing evidence on mast cell involvement in angiogenesis.
Main Results:
- Mast cell numbers vary across hemangioma phases: highest in involution, lowest in proliferation.
- Mast cell mediators can promote (angiogenic) or inhibit (antiangiogenic) blood vessel growth.
Conclusions:
- Mast cells play complex, stage-dependent roles in hemangioma development.
- Targeting mast cells offers potential for novel therapeutic strategies for hemangioma.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:38Inflammation
Overview
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...